Prevention of abdominal metastases after intraperitoneal injection of Yoshida ascites cells: use of a new colloidal 32P-chromic phosphate.
D000008:Abdominal Neoplasms / Q000517:prevention & control*; D000143:Acids; D000291:Adnexal Diseases / Q000517:prevention & control; D000818:Animals; D002857:Chromium / Q000627:therapeutic use*; D003102:Colloids / Q000627:therapeutic use*; D005260:Female; D007274:Injections, Intraperitoneal; D007414:Intestinal Neoplasms / Q000517:prevention & control; D008297:Male; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009368:Neoplasm Transplantation; D010190:Pancreatic Neoplasms / Q000517:prevention & control; D010534:Peritoneal Neoplasms / Q000517:prevention & control; D010710:Phosphates / Q000627:therapeutic use*; D010759:Phosphorus Isotopes; D051381:Rats; D012517:Sarcoma, Yoshida / Q000517:prevention & control*
D000143:Acids; D003102:Colloids; D010710:Phosphates; D010759:Phosphorus Isotopes; D002857:Chromium